Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Android™ device!
Free
Faster access than browser!
 

Chronic myelomonocytic leukemia and Panobinostat

Shortcuts: Differences, Similarities, Jaccard Similarity Coefficient, References.

Difference between Chronic myelomonocytic leukemia and Panobinostat

Chronic myelomonocytic leukemia vs. Panobinostat

Chronic myelomonocytic leukaemia (CMML) is a type of leukaemia, which are cancers of the blood-forming cells of the bone marrow. Panobinostat (trade name Farydak) is a drug by Novartis for the treatment of various cancers.

Similarities between Chronic myelomonocytic leukemia and Panobinostat

Chronic myelomonocytic leukemia and Panobinostat have 3 things in common (in Unionpedia): Anemia, European Medicines Agency, Myelodysplastic syndrome.

Anemia

Anemia is a decrease in the total amount of red blood cells (RBCs) or hemoglobin in the blood, or a lowered ability of the blood to carry oxygen.

Anemia and Chronic myelomonocytic leukemia · Anemia and Panobinostat · See more »

European Medicines Agency

The European Medicines Agency (EMA) is a European Union agency for the evaluation of medicinal products.

Chronic myelomonocytic leukemia and European Medicines Agency · European Medicines Agency and Panobinostat · See more »

Myelodysplastic syndrome

Myelodysplastic syndromes (MDS) are a group of cancers in which immature blood cells in the bone marrow do not mature and therefore do not become healthy blood cells.

Chronic myelomonocytic leukemia and Myelodysplastic syndrome · Myelodysplastic syndrome and Panobinostat · See more »

The list above answers the following questions

Chronic myelomonocytic leukemia and Panobinostat Comparison

Chronic myelomonocytic leukemia has 99 relations, while Panobinostat has 51. As they have in common 3, the Jaccard index is 2.00% = 3 / (99 + 51).

References

This article shows the relationship between Chronic myelomonocytic leukemia and Panobinostat. To access each article from which the information was extracted, please visit:

Hey! We are on Facebook now! »